Market Access News | pharmaphorum

News

MHRA gives Alnylam 'innovation passport' for hypertension dr...

The UK medicines regulator has awarded Alnylam's RNAi-based therapy zilebesiran for hypertension an 'innovation passport', a

News

FDA clears GSK's Priorix, first new MMR vaccine in 50 years

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi

News

Roche puts pressure on SMA rivals with new FDA approval

Roche and PTC Therapeutics' Evrysdi for spinal muscular atrophy (SMA) has been approved by the FDA for younger children with the rare disease, extending its use to include infants less than

News

UK grants early access to Argenx' efgartigimod for myastheni...

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG) to get early access to Argenx' efgartigimod while it reviews the marketing applic

News

Equity_World_Access_Map_1140x675_CountryList

Pfizer makes non-profit pledge for low-income nations

US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world's poorest countries – including new launches.

News

Dermavant claims its first approval as FDA clears psoriasis ...

Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama, a drug for psoriasis that it claims could be a game-changer in th

MHRA gives Alnylam 'innovation passport' for hypertension dr...

FDA clears GSK's Priorix, first new MMR vaccine in 50 years

Roche puts pressure on SMA rivals with new FDA approval

UK grants early access to Argenx' efgartigimod for myastheni...

Pfizer makes non-profit pledge for low-income nations

Dermavant claims its first approval as FDA clears psoriasis ...

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks